Related Experiment Video
Updated: Dec 1, 2025
07:28
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
41.1K
Short-acting inhaled β2-agonists: why, whom, what, how?
Andrzej Emeryk1, Justyna Emeryk-Maksymiuk2
1Klinika Chorób Płuc i Reumatologii Dziecięcej, Uniwersytet Medyczny w Lublinie. andrzejemeryk@plusnet.pl.
Advances in Respiratory Medicine
|November 10, 2020
Summary
Inhaled short-acting beta2-agonists (SABA) effectively manage obstructive lung diseases in children and adults. This review details their safety, efficacy, and therapeutic recommendations for conditions like asthma and COPD.
Area of Science:
- Pulmonology
- Pharmacology
Background:
- Obstructive lung diseases, including asthma and COPD, affect millions globally.
- Short-acting beta2-agonists (SABA) are cornerstone therapies for symptom relief.
Purpose of the Study:
- To review the efficacy and safety of inhaled SABAs (salbutamol, fenoterol) in pediatric and adult obstructive airway diseases.
- To outline current therapeutic recommendations for SABA use.
Main Methods:
- Literature review of studies on SABA efficacy and safety.
- Analysis of mechanisms of action, clinical effects, and side effect profiles.
- Synthesis of current clinical guidelines for SABA in obstructive diseases.
Main Results:
- Inhaled SABAs demonstrate significant bronchodilator effects.
- Established safety profiles with manageable side effects when used appropriately.
- Clear indications for SABA in managing acute symptoms of asthma and COPD.
Conclusions:
- SABA are essential for rapid symptom relief in obstructive airway diseases.
- Appropriate use of SABAs is supported by extensive efficacy and safety data.
- Guidelines emphasize the role of SABAs as rescue medication in asthma and COPD management.
Related Concept Videos
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
1.5K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.5K
01:23Inhaled Medications
567
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
567
01:17Drugs Used in Lower Respiratory Disorders: Overview
864
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
864
01:30Asthma-IV: Diagnostic and Management
2.9K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.9K
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.3K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.3K
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
1.4K
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
1.4K